Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -22.30% is 16% above its 5-year average of -26.65%, around the middle of its 5-year range (-37.78%–-14.48%).
As of the fiscal period ended Tuesday, June 30, 2026. 12.38% above its 12-month average of -25.45%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -22.30%.
RETURN ON INVESTED CAPITAL (ROIC)
-22.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-25.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-27.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-26.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+12.38%
CURRENT VS 3Y AVG
+19.36%
CURRENT VS 5Y AVG
+16.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 825 covered companies
CURRENT VS SECTOR MEDIAN
+37.47%
vs the sector median at left
Kymera Therapeutics, Inc.
Market Cap
$8.58B
Return on Invested Capital (ROIC)
-22.30%
TTM Avg
-25.45%
3Y Avg
-27.65%
5Y Avg
-26.65%
Market Cap
$8.74B
Return on Invested Capital (ROIC)
-12.12%
TTM Avg
-26.48%
3Y Avg
-28.91%
5Y Avg
-26.88%
Market Cap
$8.79B
Return on Invested Capital (ROIC)
6.74%
TTM Avg
5.23%
3Y Avg
-19.49%
5Y Avg
-23.68%
Market Cap
$8.37B
Return on Invested Capital (ROIC)
22.98%
TTM Avg
-12.21%
3Y Avg
-17.44%
5Y Avg
-20.18%
Market Cap
$8.98B
Return on Invested Capital (ROIC)
2.56%
TTM Avg
2.83%
3Y Avg
6.99%
5Y Avg
7.71%
Market Cap
$9.01B
Return on Invested Capital (ROIC)
-50.82%
TTM Avg
-63.49%
3Y Avg
-63.78%
5Y Avg
-84.79%
Market Cap
$7.95B
Return on Invested Capital (ROIC)
9.94%
TTM Avg
10.71%
3Y Avg
-31.72%
5Y Avg
-47.51%
Market Cap
$7.93B
Return on Invested Capital (ROIC)
14.76%
TTM Avg
-51.69%
3Y Avg
-63.43%
5Y Avg
-49.69%
Market Cap
$9.27B
Return on Invested Capital (ROIC)
2.56%
TTM Avg
2.83%
3Y Avg
6.99%
5Y Avg
7.71%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | $8.58B | -22.30% | -25.45% | -27.65% | -26.65% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.74B | -12.12% | -26.48% | -28.91% | -26.88% |
| Protagonist Therapeutics, Inc. (PTGX)vs › | $8.79B | 6.74% | 5.23% | -19.49% | -23.68% |
| Oscar Health, Inc. (OSCR)vs › | $8.37B | 22.98% | -12.21% | -17.44% | -20.18% |
| Bruker Corporation (BRKRP)vs › | $8.98B | 2.56% | 2.83% | 6.99% | 7.71% |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.01B | -50.82% | -63.49% | -63.78% | -84.79% |
| TG Therapeutics, Inc. (TGTX)vs › | $7.95B | 9.94% | 10.71% | -31.72% | -47.51% |
| Caris Life Sciences, Inc. (CAI)vs › | $7.93B | 14.76% | -51.69% | -63.43% | -49.69% |
| Bruker Corporation (BRKR)vs › | $9.27B | 2.56% | 2.83% | 6.99% | 7.71% |
| Vaxcyte, Inc. (PCVX)vs › | $9.34B | -40.65% | -24.67% | -27.62% | -28.57% |
ROIC
-22.3%
ROE
-19.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -22.30% |
| 2026-03-31 | -22.36% |
| 2025-12-31 | -20.88% |
| 2025-09-30 | -31.82% |
| 2025-06-30 | -29.89% |
| 2025-03-31 | -32.38% |
| 2024-12-31 | -28.74% |
| 2024-09-30 | -20.67% |
| 2024-06-30 | -24.29% |
| 2024-03-31 | -21.92% |
| 2023-12-31 | -33.78% |
| 2023-09-30 | -37.78% |
| 2023-06-30 | -32.66% |
| 2023-03-31 | -30.73% |
| 2022-12-31 | -30.32% |
| 2022-09-30 | -28.61% |
| 2022-06-30 | -32.20% |
| 2022-03-31 | -26.18% |
| 2021-12-31 | -19.58% |
| 2021-09-30 | -14.48% |
| 2021-06-30 | -18.04% |
| 2021-03-31 | -13.61% |
| 2020-12-31 | -12.30% |
| 2020-09-30 | -11.32% |
| 2020-06-30 | -35.46% |
